How much gets through? Aesthetic Peptide Research Review

Copper depot

A piece of skin can hold on to what passes through it. In an experiment using human skin removed for laboratory testing, copper applied as GHK-Cu crossed the tissue, while some stayed in the dermis, the deeper skin layer. The researchers described a copper depot. A copper depot has some heft to it. I picture material lingering in a layer of tissue, an image with more substance than the usual language of rejuvenation.

This was an ex vivo experiment, meaning work on tissue outside the body. In dermatomed skin, a prepared skin specimen, the researchers measured 136.2 ± 17.5 micrograms of copper per square centimeter passing through over 48 hours, and 97 ± 6.6 micrograms per square centimeter retained in the dermis. Those are copper measurements. The retained amount does not tell us that the entire copper-peptide complex stayed intact, or that a face became smoother.

I like the skin’s stubborn presence in this experiment. An aesthetic ambition has to contend with this material: its layers, what they admit and what they retain. That is why GHK-Cu comes first here, even though Melanotan II has the more conspicuous visible effect.

The outer layer

GHK is attracted to water and crosses skin’s outer barrier poorly. A review of topical GHK and delivery methods treats that obstacle as a central problem. It discusses changes to the molecule and ways of getting more through. Each intervention changes the experiment as well as the amount delivered.

I’m happier discussing the cream as a material than trading grand claims about rejuvenation. A cream is a formulation meeting a surface, with chemistry happening on both sides. GHK without copper, copper bound to GHK and a modified peptide require their own names. The appealing biological effects described in the skin-regeneration literature still have to survive that encounter with a real barrier.

Pigment production

Melanotan II reaches the surface by another route: it stimulates pigment production inside skin cells. In the small pilot study of pigmentation, two of three healthy men developed darker skin. Spontaneous erections and mild nausea were recorded too. A cosmetic intention left researchers watching much more than colour.

Calling all this “tanning” feels implausibly tidy to me. The Melanotan II page follows pigment production into the human studies and the reports of harm. Melanotan II remains unapproved for human treatment; its history within the melanocortin family also involves distinct compounds whose regulatory histories cannot be transferred to it.

Repair and the GLOW blend

GLOW usually brings GHK-Cu together with BPC-157 and TB-500. Its appeal rests on tissue support, new blood vessels and migrating cells. A review discussing all these constituents describes encouraging animal findings alongside scarce rigorous human safety data and the potential for serious harm. There is no controlled human trial of the blend in this research record.

I’m drawn to coordinated repair even while the mixture’s chemistry remains unresolved. The skin experiment makes the practical questions harder to shrug off: which material reaches which layer, in what form, and what happens there? GLOW adds unresolved compatibility and combined-distribution questions to the limited human evidence for its ingredients. The comparison puts colour, copper and repair alongside one another without pretending the studies can pick a treatment.